Sequential systemic treatment in patients with hepatocellular carcinoma-Reference-Cited by-同舟云学术

Sequential systemic treatment in patients with hepatocellular carcinoma

Published:2020-05-20 Issue:1 Volume:52 Page:205-212
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Kirstein Martha M.¹²^ORCID,Scheiner Bernhard³^ORCID,Marwede Tristan¹,Wolf Caroline¹,Voigtländer Torsten¹,Semmler Georg³^ORCID,Wacker Frank⁴,Manns Michael P.¹^ORCID,Hinrichs Jan B.⁴,Pinter Matthias³^ORCID,Vogel Arndt¹

Affiliation:

1. Department of Gastroenterology, Hepatology and Endocrinology; Hannover Medical School; Hannover Germany

2. Department of Medicine I; University Medical Center Schleswig-Holstein; Lübeck Germany

3. Division of Gastroenterology and Hepatology; Department of Internal Medicine III; Medical University of Vienna; Vienna Austria

4. Institute for Diagnostic and Interventional Radiology; Hannover Medical School; Hannover Germany

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15789/fullpdf

Reference23 articles.

1. Hepatocellular carcinoma;El-Serag;N Engl J Med,2011

2. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

3. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

4. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial;Kudo;Lancet,2018

5. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial;Bruix;Lancet,2017

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letter: Presence of progression or absence of response? Alternative trial designs for immunotherapy of advanced hepatocellular carcinoma;Alimentary Pharmacology & Therapeutics;2024-04-21

2. Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma: Real-life Data on Liver Disease, Treatment and Prognosis;Journal of Clinical and Translational Hepatology;2023-05-16

3. MUW researcher of the month;Wiener klinische Wochenschrift;2023-02

4. Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma;JHEP Reports;2023-01

5. Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular Carcinoma;Internal Medicine;2022-11-01